Browse by Journal

Schwalbe, Edward C and H, Lalchungnunga and Lafta, Fadhel and Barrow, Timothy M and Strathdee, Gordon (2021) Integration of genome-level data to allow identification of subtype-specific vulnerability genes as novel therapeutic targets. Oncogene, 40 (33). pp. 5213-5223. DOI https://doi.org/10.1038/s41388-021-01923-1

Cronin, Ryan and Brooke, Greg N and Prischi, Filippo (2021) The role of the p90 ribosomal S6 kinase family in prostate cancer progression and therapy resistance. Oncogene, 40 (22). pp. 3775-3785. DOI https://doi.org/10.1038/s41388-021-01810-9

Harrod, A and Fulton, J and Nguyen, VTM and Periyasamy, M and Ramos-Garcia, L and Lai, C-F and Metodieva, G and de Giorgio, A and Williams, RL and Santos, DB and Gomez, PJ and Lin, M-L and Metodiev, MV and Stebbing, J and Castellano, L and Magnani, L and Coombes, RC and Buluwela, L and Ali, S (2017) Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer. Oncogene, 36 (16). pp. 2286-2296. DOI https://doi.org/10.1038/onc.2016.382

Chudasama, P and Konrad, A and Jochmann, R and Lausen, B and Holz, P and Naschberger, E and Neipel, F and Britzen-Laurent, N and Stürzl, M (2015) Structural proteins of Kaposi's sarcoma-associated herpesvirus antagonize p53-mediated apoptosis. Oncogene, 34 (5). pp. 639-649. DOI https://doi.org/10.1038/onc.2013.595

Dart, DA and Brooke, GN and Sita-Lumsden, A and Waxman, J and Bevan, CL (2012) Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens. Oncogene, 31 (43). pp. 4588-4598. DOI https://doi.org/10.1038/onc.2011.591

Brooke, GN and Parker, MG and Bevan, CL (2008) Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression. Oncogene, 27 (21). pp. 2941-2950. DOI https://doi.org/10.1038/sj.onc.1210955

Mohr, A and Büneker, C and Gough, RP and Zwacka, RM (2008) MnSOD protects colorectal cancer cells from TRAIL-induced apoptosis by inhibition of Smac/DIABLO release. Oncogene, 27 (6). pp. 763-774. DOI https://doi.org/10.1038/sj.onc.1210673

Gamble, SC and Chotai, D and Odontiadis, M and Dart, DA and Brooke, GN and Powell, SM and Reebye, V and Varela-Carver, A and Kawano, Y and Waxman, J and Bevan, CL (2007) Prohibitin, a protein downregulated by androgens, represses androgen receptor activity. Oncogene, 26 (12). pp. 1757-1768. DOI https://doi.org/10.1038/sj.onc.1209967

La Ferla-Brühl, K and Westhoff, MA and Karl, S and Kasperczyk, H and Zwacka, RM and Debatin, KM and Fulda, S (2007) NF-κB-independent sensitization of glioblastoma cells for TRAIL-induced apoptosis by proteasome inhibition. Oncogene, 26 (4). pp. 571-582. DOI https://doi.org/10.1038/sj.onc.1209841

Kasperczyk, Hubert and La Ferla-Brühl, Katia and Westhoff, Mike Andrew and Behrend, Lars and Zwacka, Ralf Michael and Debatin, Klaus-Michael and Fulda, Simone (2005) Betulinic acid as new activator of NF-κB: molecular mechanisms and implications for cancer therapy. Oncogene, 24 (46). pp. 6945-6956. DOI https://doi.org/10.1038/sj.onc.1208842

Mohr, Andrea and Zwacka, Ralf Michael and Jarmy, Gergely and Büneker, Chirlei and Schrezenmeier, Hubert and Döhner, Konstanze and Beltinger, Christian and Wiesneth, Markus and Debatin, Klaus-Michael and Stahnke, Karsten (2005) Caspase-8L expression protects CD34+ hematopoietic progenitor cells and leukemic cells from CD95-mediated apoptosis. Oncogene, 24 (14). pp. 2421-2429. DOI https://doi.org/10.1038/sj.onc.1208432